|
Home | Medical-Newswire.Com:
|
(EMAILWIRE.COM, December 14, 2011 ) Chicago, Illinois - The Stockfather (www.thestockfather.com) reports that Alimera Sciences, Inc. (NasdaqGM: ALIM) believes that it is quite possible that Iluvien could be approved for sale in Europe.
Europe is far more lenient than America is, when it comes to approving drugs and therapies for illness.
On Monday, shares of Alimera Sciences Inc. (ALIM) gained over 27%, Tuesday however, (ALIM) gave back much of Monday's gains.
Look for a strong rebound today, and look for (ALIM) to continue to run into next week.
A decision on Iluvien is supposed to be out by the end of December 2011.
Sirius XM Radio Inc. (NasdaqGS: SIRI) is starting to show some life, the last couple of trading days have been very good for SIRI, and has seen (SIRI) move up .07 to .08 cents, instead of the usual .03 cents up one day, .02 cents down the next day.
Look for Sirius XM Radio Inc. (SIRI) to continue to move up in the coming days.
Bank of America Corporation (NYSE: BAC) is a gigantic bank, but their stock has been anything but gigantic lately, but now (BAC) seems to have found its base, and should be back past $6 by the new year.
Nokia Corporation (NYSE: NOK) is currently trading near its 52 week low. Nokia Corporation (NYSE: NOK) has a 52 week range of $4.82 - $11.75.
Look for (NOK) to have a strong finish into 2012.
Boston Scientific Corporation (NYSE: BSX) is trading near its 52 week low, .10 cents from it as a matter of fact.
Boston Scientific Corporation (BSX) has a 52 week range of $5.23 - $7.96.
Boston Scientific Corporation (BSX) isn't a very flashy stock, but it is a relatively safe stock, and one for holding long.
Thestockfather.com likes all of the stocks, but considers (ALIM) the one with the most potential out of the five mentioned, and a "Strong Buy".
To join The Stockfather's stock alert email newsletter, visit their site at http://www.thestockfather.com.
About The Stockfather:
The Stockfather searches the markets (from OTC to NYSE) for stocks positioned to make big gains. Stocks and companies are featured on The Stockfather web site and e-newsletter.
Disclaimer:
For this news release, The Stockfather was not paid to profile the company(ies) or stock(s) mentioned. The Stockfather does not own any shares of the stock(s) mentioned. The Stockfather is not a registered investment advisor. Investors are responsible for doing their own research and obtaining professional investment advice. Investors should visit www.thestockfather.com for further disclosure information.
The Stockfather
David Conway
312-473-5916
alerts@thestockfather.com 
Source: EmailWire.com
|
|
|
|
